Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Genetic variation in thrombin-activatable fibrinolysis inhibitor is associated with the risk of diabetic nephropathy.

Xu CW, Wu XB, Ma XL, Wang YS, Zhang BC, Zhao JJ, Wang ZJ, Chen J.

J Endocrinol Invest. 2012 Jul;35(7):620-4.

PMID:
22932273
2.

Effect of single nucleotide polymorphism in thrombin-activatable fibrinolysis inhibitor on the risk of diabetic macrovascular disease.

Zheng C, Li X, Kong C, Ke S, Peng C, Cui T, Gao M, Zhou Y, Guo W, Huang L, Petersen RB, Huang K.

Blood Coagul Fibrinolysis. 2015 Mar;26(2):185-90. doi: 10.1097/MBC.0000000000000216.

PMID:
25396763
3.

[Correlation analysis of thrombin-activatable fibrinolysis inhibitor single nucleotide polymorphism with venous thromboembolism].

Li C, Hou LH, Liu XE, Huang C, Wei XH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Aug;20(4):949-53. Chinese.

PMID:
22931662
4.

Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria.

Yano Y, Kitagawa N, Gabazza EC, Morioka K, Urakawa H, Tanaka T, Katsuki A, Araki-Sasaki R, Hori Y, Nakatani K, Taguchi O, Sumida Y, Adachi Y.

J Clin Endocrinol Metab. 2003 Feb;88(2):736-41.

PMID:
12574207
5.

Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis.

Qian K, Xu J, Wan H, Fu F, Lu J, Lin Z, Liu Z, Liu H.

Gene. 2015 Sep 15;569(2):173-81. doi: 10.1016/j.gene.2015.06.014. Epub 2015 Jun 10. Review.

PMID:
26071134
6.

Novel ERBB receptor feedback inhibitor 1 (ERRFI1) + 808 T/G polymorphism confers protective effect on diabetic nephropathy in a Korean population.

Lee IS, Lee JH, Kim HJ, Lee JM, Lee SK, Kim HS, Lee JM, Park KS, Ku BJ.

Dis Markers. 2013;34(2):113-24. doi: 10.3233/DMA-120949.

7.

Association of myeloperoxidase G-463A gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic subjects.

Katakami N, Kume S, Kaneto H, Uzu T, Kashiwagi A, Yamasaki Y, Maegawa H, Shimomura I.

Endocr J. 2013;60(4):457-71. Epub 2012 Dec 24.

8.

BsmI polymorphisms in vitamin D receptor gene are associated with diabetic nephropathy in type 2 diabetes in the Han Chinese population.

Zhang H, Wang J, Yi B, Zhao Y, Liu Y, Zhang K, Cai X, Sun J, Huang L, Liao Q.

Gene. 2012 Mar 10;495(2):183-8. doi: 10.1016/j.gene.2011.12.049. Epub 2012 Jan 5.

PMID:
22245613
9.

Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.

Wang Y, Ng MC, Lee SC, So WY, Tong PC, Cockram CS, Critchley JA, Chan JC.

Diabetes Care. 2003 Aug;26(8):2410-5.

PMID:
12882871
10.

Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus.

Araki S, Ng DP, Krolewski B, Wyrwicz L, Rogus JJ, Canani L, Makita Y, Haneda M, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2003 Aug;14(8):2015-24.

11.

[Thrombin activatable fibrinolysis o inhibitor-TAFI- in dialyzed patients with diabetic nephropathy].

Małyszko JS, Małyszko J, Hryszko T, Myśliwiec M.

Pol Arch Med Wewn. 2003 Aug;110(2):843-8. Polish.

PMID:
14682222
12.

The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancer.

Vairaktaris E, Yapijakis C, Nkenke E, Vassiliou S, Vylliotis A, Nixon AM, Derka S, Ragos V, Spyridonidou S, Tsigris C, Neukam FW, Patsouris E.

Am J Hematol. 2007 Nov;82(11):1010-2.

13.

Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients.

Maltais I, Bachvarova M, Maheux P, Perron P, Marceau F, Bachvarov D.

Can J Physiol Pharmacol. 2002 Apr;80(4):323-7.

PMID:
12025967
14.

Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy.

Liu L, Xiang K, Zheng T, Zhang R, Li M, Li J.

Mol Cell Biochem. 2003 Dec;254(1-2):353-8.

PMID:
14674716
15.

Oxidative stress and its association with TNF-α-308 G/C and IL-1α-889 C/T gene polymorphisms in patients with diabetes and diabetic nephropathy.

Dabhi B, Mistry KN.

Gene. 2015 May 15;562(2):197-202. doi: 10.1016/j.gene.2015.02.069. Epub 2015 Feb 27.

PMID:
25732517
16.

The association of the 174G>C polymorphism of interleukin 6 gene with diabetic nephropathy in patients with type 2 diabetes mellitus.

Papaoikonomou S, Tentolouris N, Tousoulis D, Papadodiannis D, Miliou A, Papageorgiou N, Hatzis G, Stefanadis C.

J Diabetes Complications. 2013 Nov-Dec;27(6):576-9. doi: 10.1016/j.jdiacomp.2013.06.006. Epub 2013 Jul 19.

PMID:
23871133
17.

Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.

Ezzidi I, Mtiraoui N, Kacem M, Chaieb M, Mahjoub T, Almawi WY.

Diabetes Metab Res Rev. 2009 Nov;25(8):717-24. doi: 10.1002/dmrr.1006.

PMID:
19787680
18.

The C825T polymorphism in the human G-protein beta3 subunit gene is not associated with diabetic nephropathy in Type I diabetes mellitus.

Fogarty DG, Zychma MJ, Scott LJ, Warram JH, Krolewski AS.

Diabetologia. 1998 Nov;41(11):1304-8.

PMID:
9833937
19.

The Leu72Met polymorphism of the GHRL gene prevents the development of diabetic nephropathy in Chinese patients with type 2 diabetes mellitus.

Zhuang L, Li M, Yu C, Li C, Zhao M, Lu M, Zheng T, Zhang R, Zhao W, Bao Y, Xiang K, Jia W, Wang N, Liu L.

Mol Cell Biochem. 2014 Feb;387(1-2):19-25. doi: 10.1007/s11010-013-1865-6. Epub 2013 Oct 17.

PMID:
24132517
20.

Uromodulin gene variant is associated with type 2 diabetic nephropathy.

Ahluwalia TS, Lindholm E, Groop L, Melander O.

J Hypertens. 2011 Sep;29(9):1731-4. doi: 10.1097/HJH.0b013e328349de25.

PMID:
21738052

Supplemental Content

Support Center